Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2025

Genmab — Maj 2025

Planlagt Fastgjort Låst Flyttet Genmab
308 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #99

    $3bn in peaksale would close the gap from dara -in revenue, wouldn't it, before development and sales cost

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #100

      But a very big issue is still that Genmab is not even close to do global sales - and this will not happen before Darzalex royalty expire

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #101

        And peaksales for RinaS will take many years to build up

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #102

          sure. but if you don't have the aspirations you'll never get there. It also works the other way around right -if you have a drug that gives you the confidence it will be a big seller, it will also give you the confidence to ramp up the sales organisation.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #103

            They'll have to start with Tivdak in europe this year, still a smaller drug, but similar patient group, so it is the same trajectory they will need to follow for Rina-S

            1 Reply Last reply
            0
            • W Offline
              W Offline
              w
              wrote on sidst redigeret af
              #104

              @17.43. If that was not the case. PE would have been far above 10

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #105

                Godmorgen 🙂

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #106

                  Trump vil presse medicinpriserne markant ned i USA https://www.dr.dk/nyheder/udland/trump-vil-saenke-priserne-paa-medicin-i-usa-markant

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #107

                    "Nyhedsbureauet AP skriver, at Trumps forslag sandsynligvis kun vil sænke priserne på de lægemidler, der er dækket af den offentlige sundhedsforsikring Medicare.

                    Medicare udgør en hjørnesten i det amerikanske sundhedssystem og sikrer sundhedsdækning for omkring 70 millioner ældre borgere".

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #108

                      Er Donald Trump medicinmanden med de lavere priser? https://proinvestor.com/boards/126321

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        LP90
                        wrote on sidst redigeret af
                        #109

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #110

                          Puha det kan blive volatilt med de udmeldinger. Trump mener, at priserne på medicin skal ned med 30-80% i USA.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #111

                            this was why we went down on Thursday already , didn't we...

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #112

                              Dose Selection for DuoBody®-CD40x4-1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.3677

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Plimsoller
                                wrote on sidst redigeret af
                                #113

                                Vi får en ordentlig en på hatten lige nu. Lad os se hvad der sker i løbet af dagen. Sidste gang han forsøgte noget lignende blev han jo stoppet af domstolene.

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  LP90
                                  wrote on sidst redigeret af
                                  #114

                                  den her case har udviklet sig til et mareridt for rigtig mange incl. mig selv øv øv øv

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #115

                                    Her er jeg total i chok!..... Jeg fatter ikke en skid af det der foregår..... Hvorfor er Genmab den aktie der konstant skal rammes hårdest, når idioten DT åbner sin mund?..... Genmab hører vel til den gruppe der bliver mindst ramt af DT tankespind...

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raun
                                      wrote on sidst redigeret af
                                      #116

                                      ??.... På bare en uge har Genmab aktien smidt over 15%... Og det ovenikøbet med et godt regnskab inkluderet?

                                      1 Reply Last reply
                                      0
                                      • R Offline
                                        R Offline
                                        Raun
                                        wrote on sidst redigeret af
                                        #117

                                        I samme periode har Novo mistet 4-5?.... Vil nogen ikke være søde og forsøge at få mig til at fatte det!?

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #118

                                          UBS lowers target price for Genmab to DKK 2,600 (2,700), reiterates buy recommendation
                                          May12/2025

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper